P

Protagonist Therapeutics
D

PTGX

45.550
USD
0.55
(1.22%)
مغلق
حجم التداول
24,773
الربح لكل سهم
-1
العائد الربحي
-
P/E
11
حجم السوق
2,822,151,827
أصول ذات صلة
B
BEAM
0.400
(2.02%)
20.210 USD
B
BLUE
-0.15000
(-3.69%)
3.91000 USD
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
MRNA
MRNA
0.600
(2.22%)
27.590 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
VRTX
VRTX
2.22
(0.45%)
500.92 USD
المزيد
الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.